Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
ROE: Returns Declining
Trending higher, below historical average.
Left:
||||
Return on equity
Latest
-29.01%
↓ 309% below average
Average (8y)
13.90%
Historical baseline
Range
High:276.68%
Low:-173.34%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -29.01% | +83.3% |
| 2023 | -173.34% | -102.0% |
| 2022 | -85.83% | -123.0% |
| 2021 | -38.49% | -32.2% |
| 2020 | -29.11% | -122.8% |
| 2019 | 127.46% | -53.9% |
| 2018 | 276.68% | +814.3% |
| 2017 | 30.26% | -34.9% |
| 2016 | 46.51% | - |